Home/enGene/Jason Hanson

JH

Jason Hanson

Chief Executive Officer

Therapeutic Areas

Oncology Inflammatory Diseases Genetic Disorders

enGene Pipeline

Drug	Indication	Phase
EG-70	BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in Situ (CIS)	Phase 1/2

Leadership Team at enGene

Chief Scientific Officer and Co-Founder

Richard Gammans

Chief Development Officer

Chief Medical Officer

Chief Financial Officer

View full enGene profile